Multiple schwannomas: Schwannomatosis or neurofibromatosis type 2?

Journal of Neurosurgery

Volumn 89, Issue 1, 1998, Pages 36-41

  Seppälä, Matti Tapio ^a   Sainio, Markku Alarik ^b   Haltia, Matti Jouko Johannes ^b   Kinnunen, Jaakko Jyri ^b   Setälä, Kirsi Hannele ^b   Jääskeläinen, Juha Erik ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

Neurofibromatosis type 1; Neurofibromatosis type 2; Outcome; Schwannoma; Schwannomatosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0343484335     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.1.0036     Document Type: Article

References (27)

1. Egelhoff JC, Bates DJ, Ross JS, et al: Spinal MR findings in neurofibromatosis types 1 and 2. AJNR 13:1071-1077, 1992
2. Evans DGR, Huson SM, Donnai D, et al: A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618, 1992
3. Evans DGR, Mason S, Huson SM, et al: Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry 62:361-366, 1997
4. Garretto NS, Monteverde D, Giocóli H, et al: Schwannomatosis: presentacion de un nuevo caso. Arq Neuropsiquiatr 50:539-542, 1992
5. Gutmann DH: Molecular insights into neurofibromatosis 2. Neurobiol Dis 3:247-261, 1997
6. Gutmann DH, Aylsworth A, Carey JC, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57, 1997
7. Halliday AL, Sobel RA, Martuza RL: Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74:248-253, 1991
8. Honda M, Arai E, Sawada S, et al: Neurofibromatosis 2 and neurilemmomatosis gene are identical. J Invest Dermatol 104: 74-77, 1995
9. Jacoby LB, Jones D, Davis K, et al: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61:1293-1302, 1997
10. Jacoby LB, MacCollin M, Louis DN, et al: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419, 1994
11. Kehoe NJS, Reid RP, Semple JC: Solitary benign peripheral-nerve tumours. Review of 32 years' experience. J Bone Joint Surg (Br) 77:497-500, 1995
12. Ko JY, Wang JW, Wan YL, et al: Multiple schwannomas of the foot: report of a case. J Formos Med Assoc 92:845-847, 1993
13. Louis DN, Ramesh V, Gusella JF: Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5:163-172, 1995
14. MacCollin M, Woodfin W, Kronn D, et al: Schwannomatosis: a clinical and pathologic study. Neurology 46:1072-1079, 1996
15. Marchuk DA, Saulino AM, Tavakkol R, et al: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11:931-940, 1991
16. Matsuo A, Tooyama I, Akiguchi I, et al: [A case of schwanno-matosis-clinical pathological and biochemical studies.] Rinsho Shinkeigaku 31:742-745, 1991 (Jpn)
17. Mautner VF, Tatagiba M, Lindenau M, et al: Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety. AJR 165:951-955, 1995
18. Murray RJ, Criner GJ, Siegel E: Multiple schwannomas presenting as a mass of the lateral chest wall. AJR 151: 1250-1251, 1988 (Letter)
19. National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 45:575-578, 1988
20. Purcell SM, Dixon SL: Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity? Arch Dermatol 125:390-393, 1989
21. Rouleau GA, Merel P, Lutchman M, et al: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521, 1993
22. Ruttledge MH, Andermann AA, Phelan CM, et al: Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet 59: 331-342, 1996
23. Seppälä MT, Haltia MJJ, Sankila RJ, et al: Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg 83:621-626, 1995
24. Shank CP, Friedman WA: Ulnar neuropathy in a patient with multiple schwannomas of the ulnar nerve. Surg Neurol 28: 153-157, 1987
25. Shishiba T, Niimura M, Ohtsuka F, et al: Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis. J Am Acad Dermatol 10:744-754, 1984
26. Sobel RA, Wang Y: Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J Neuropathol Exp Neurol 52:106-113, 1993
27. Trofatter JA, MacCollin MM, Rutter JL, et al: A novel Moesin-, Ezrin-, Radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993